Contact Us | 1-877-576-3636

Click the HTML icon in the toolbar above to adjust vertical this spacer.
TO EDIT: Change the class="spacer-3" to any number between 0 (none) and 5 (most) to resize a spacer. Ex. class="spacer-5"
Vertical spacers are responsive and 50% smaller on mobile than on tablet+.
iCE3 Virtual User Meeting


Webinar: iCE3 Virtual User Meeting: Making the Transition to Maurice Platforms


September 24, 2025
Broadcast 1: 9 AM, ET, 2 PM UTC, 3 PM CET
Broadcast 2: 11 AM PT, 1:00 PM CT, 2 PM ET

Since 2013, the iCE3 system has provided fast, high resolution charge variant analysis and has been utilized for the QC release of almost 300 commercial products. Following its discontinuation on December 31, 2021, iCE3 users have been successfully transitioning to the Maurice and MauriceFlex platforms.

All current iCE3 Users are invited to join us at one of our upcoming Virtual User Meetings. There are two broadcast times to accommodate users in both Europe and North America.

Our featured speakers, Anne Ries (Boehringer Ingelheim) and John Orlet (Pfizer), have been part of successful bridging studies and will share their experience in instrument changes, bridging study designs and results, technical tips, and best practices. In addition, you will learn about the data comparability between iCE3 & Maurice, along with additional capabilities Maurice platforms offer. The talks will be followed by live panel discussions with industry experts to answer any questions you might have about planning for and successfully transitioning from the iCE3 to Maurice platforms.

Session 1 (14:00 UTC):
  • Moderator: JF Bellec, Bio-Techne
  • Featured Talk: Universal Study Design for Instrument Changes in Pharmaceutical Release Analytics - Anne Ries, Boehringer Ingelheim
  • Panelists for Discussion: Anne Ries (Boehringer Ingelheim), Silvia Caciolli (Lonza), Peter Johnson (Bio-Techne)

Anne Ries
Anne Ries
Boehringer Ingelheim
Silvia Caciolli
Silvia Caciolli
Lonza

Session 2 (11:00 AM Pacific Time):
  • Moderator: Ed Chase, Bio-Techne
  • Featured Talk: Enabling Continuity of Biomolecular Charge Variant Analysis: Equivalency Evaluation of Maurice and iCE3 Instruments - John Orlet, Pfizer
  • Panelists for Discussion: John Orlet (Pfizer), Seth Madren (Biogen), Will McElroy (Bio-Techne)

John Orlet
John Orlet
Pfizer 
Seth Madren
Seth Madren
Biogen


Both sessions – Additional Talks: 

  • Technical Tips and Considerations for Making the Transition from iCE3 Systems to Maurice - Monica Tyagi (Bio-Techne)
  • Expanding the capabilities of your lab with Maurice and MauriceFlex Platforms - Peter Johnson (Bio-Techne)